title: Agreement between drugs-to-avoid criteria and expert assessments of problematic prescribing--invited commentary.
authors.affiliation: Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. dbudnitz@cdc.gov
authors.forename: Daniel S
authors.initials: DS
authors.lastname: Budnitz
mesh_terms: D000368:Aged; D000075202:Contraindications; D017723:Drug Utilization Review / Q000592:standards*; D006801:Humans; D004366:Nonprescription Drugs; D017063:Outcome Assessment, Health Care; D055553:Prescription Drugs; D018570:Risk Assessment
chemical_list: D004366:Nonprescription Drugs; D055553:Prescription Drugs